Journals / Endokrinolojide Yönelişler / 2002 / Cilt: 11 - Sayı: 5

Vitamin B12 levels in patients with type 2 diabetes mellitus

Tip 2 diabetes mellitus hastalarında B12 vitamin düzeyleri

Pages
200–201
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Before starting cyanocobalamin supplementation treatment for patients with type 2 diabetes mellitus, we offer to determine the B12 levels so as to prevent misuse of vitamin compounds.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vitamin B compounds through which B12 is frequently present are used in patients with type 2 diabetes mellitus as a supplementation therapy for not only the management of malnutrition but alleviating the symptoms of neuropathy, as well.
📊
Key Findings & Data:It has been reported that vitamin B12 deficiency may lead to cardiovascular morbidity owing to an increase in homocysteine levels.
💡
Conclusion & Impact:Before starting cyanocobalamin supplementation treatment for patients with type 2 diabetes mellitus, we offer to determine the B12 levels so as to prevent misuse of vitamin compounds.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Vitamin B compounds through which B12 is frequently present are used in patients with type 2 diabetes mellitus as a supplementation therapy for not only the management of malnutrition but alleviating the symptoms of neuropathy, as well. Diabetes mellitus is a well known cause of atherosclerosis. It has been reported that vitamin B12 deficiency may lead to cardiovascular morbidity owing to an increase in homocysteine levels. B12 vitamin levels of 59 type 2 diabetic patients who are admitted to KSU Medical Faculty are compared with the control group. Mean values found were higher in diabetics. Before starting cyanocobalamin supplementation treatment for patients with type 2 diabetes mellitus, we offer to determine the B12 levels so as to prevent misuse of vitamin compounds.

Özet

Diabetli hastalara gerek malnütrisyon, gerekse nöropati semptomlarının hafifletilmesi amacıyla çoğu kez aralarında B12 vitaminin de bulunduğu B vitamin bileşikleri ile destek tedavisi verilmektedir. Diabetes mellitus atherosklerozun iyi bilinen bir nedenidir. B12 vitamin eksikliğinin homosistein düzeyini arttırarak kardiyovasküler morbiditede etkili olduğu bildirilmektedir. KSÜ Tıp Fakültesi iç Hastalıkları Polikliniğine başvuran tip 2 diabetli 59 hastada, vitamin B12 düzeyi kontrol grubu ile karşılaştırılmıştır. Ortalama düzey diabetik grupta daha yüksek bulunmuştur. Siyanokobalaminle destek tedavisine başlamadan önce seviyenin belirlenerek, bu hasta grubunda vitamin savurganlığının önüne geçilebileceğini düşünmekteyiz.

🔖

Cite This Article

BÜYÜKBEŞE, M. A., ÇETİNKAYA, A. (2022). Vitamin B12 levels in patients with type 2 diabetes mellitus. Endokrinolojide Yönelişler, Cilt: 11 - Sayı: 5, 200–201. https://ajindex.com/articles/650063

References (13)

  1. Perros P, Singh RK, Ludlam CA, Frier BM: Prevalance of pernicious anaemia in patients with type 1 diabetes mellitus and autoimmun thyroid disease. Diabet Med 2000; 17(10)749-751
  2. Mueller T, Haidinger D, Luft C, Horvath W, Poelz W. Association betwe¬en erythrocyte mean corpuscular volume and peripheral arterial disease in male subjects. Angiology 2001; 52(9): 605-613. 3. http:// www.healthgate.com/eating/1997/homocyst/homocyst2.asp (Internet adresi
  3. Kessler P, Veberova J, Bradackova I: Occurence of diabetes, hyperinsu-linism and other factors for atherosclerosis in patients with pernicious anemia Vnitr Lek 1998; 44:222-226 (abstract)
  4. Stabler SP, Estacio R, Jeffers BW, Cohen JA, Allen RH, Schrier RW.: Total homocysteine is associated with nephropathy in non-insulin dependent diabetes mellitus. Metabolism 1999; 48: 1096-1101
  5. Mazza A, Motti C, Morro G, et al: Lack of association between carotid in-tima-media thickness and methyltatrahydrofolate reductase gene polymorphism or serum homocysteine in non-insulin dependent diabetes mellitus. Metabolism 2000; 49:718-723
  6. Fiorina P, laufredini M, Montanari A, et al. Plasma homocysteine and fo-late are related to arterial blood pressure in type 2 diabetes mellitus. Am J Hypertens 1998; 11: 110-1107
  7. Wollesen F, Brattström L, Refsum H, et al: Plasma total homocysteine and cysteine in relation to glomerular filtration in diabetes mellitus. Kidney Int 1999; 55: 1028-1035
  8. Chait A, Malinow MR, Nevin DN, et al: Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease. Am J Clin Nutr 1999; 70: 881-887
  9. Meigs JB, Jacques PF, Selhub J, et al. Fasting plasma homocystein levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes care 2001; 24(8): 1403-1410
  10. Refsum H, Yajnik CS, Gadkari M, et al. Hyperhomocysteinemia and elevated methylmalonic acid in a high prevalance of cobalamin deficiency in Asian Indians. Am J Clin Nutr 2001; 74(2): 233-241
  11. Takashashi Y, takayama, S, Itou T, Owada K, Omori Y: Effect of glyce- mic control on vitamin B12 metabolism in diabetes mellitus. Diabetes Res Clin Pract 1994; 25(1): 13-17
  12. Yaqub BA, Siddique A, Sulimani R: Effects of methylcobalamin on diabetic neuropathy. Clin Neurol Neurosurg 1992; 94(2): 105-111
  13. Straub RH, Rokitzki L, Schumacher T, et al: Patients with type II diabetes mellitus and neuropathies have no deficiency of vitamin A, E, betacaroten,